Company Filing History:
Years Active: 2017-2018
Title: David Stoltz: Innovator in Transgenic Research
Introduction
David Stoltz is a prominent inventor based in Iowa City, IA (US). He has made significant contributions to the field of biomedical research, particularly in the development of transgenic models for studying cystic fibrosis. With a total of 2 patents, his work has the potential to advance our understanding of this genetic disorder.
Latest Patents
Stoltz's latest patents focus on transgenic pig models of cystic fibrosis. These inventions relate to the creation of transgenic pig models, which can be used to study the disease more effectively. The patents also cover the cells that can be utilized to produce such animals, along with methods for making and using these pigs and cells. This innovative approach provides a valuable tool for researchers aiming to explore cystic fibrosis in a more comprehensive manner.
Career Highlights
David Stoltz is affiliated with the University of Iowa Research Foundation, where he conducts his research. His work has garnered attention for its potential impact on the understanding and treatment of cystic fibrosis. Stoltz's dedication to advancing medical research is evident in his innovative approaches and the patents he has secured.
Collaborations
One of his notable collaborators is Michael J Welsh, who shares a commitment to advancing research in the field of cystic fibrosis. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.
Conclusion
David Stoltz's contributions to transgenic research highlight the importance of innovation in understanding complex diseases like cystic fibrosis. His work not only furthers scientific knowledge but also opens new avenues for potential treatments.